Search for: "Boehringer, Ingelheim Pharmaceuticals, Inc."
Results 61 - 80
of 125
Sorted by Relevance
|
Sort by Date
9 Mar 2009, 7:00 am
Skylight Studios275 Hudson Street, NYC7 pm - 10 pmPURCHASE TICKETS Participating chefs Anne BurrellThe Food Network Anita LoAnnisa Pichet OngP*ONG Suvir SaranDevi Lawrence Benenson Fiona and Stanley Druckenmiller Leslie Fay Pomerantz Anita Jaffe Bloomberg Davis Polk & Wardwell Jeffrey FashionCares 2009 May and Samuel Rudin Family Foundation Sonnenschein Nath &… [read post]
6 May 2024, 8:26 am
” Warning letters were sent to 10 manufacturers, including, among others, Teva (identifying 58 listings), Novo Nordisk (36 listings), and Boehringer Ingelheim (10 listings). [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
13 Nov 2023, 4:10 pm
Boehringer Ingelheim Pharmaceuticals, Inc., Williams asks the court to grant review and reverse the 11th Circuit’s ruling. [read post]
27 Oct 2010, 9:30 am
Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals Inc. of Ridgefield, Conn., will be available in 75 milligram and 150 milligram capsules. [read post]
4 May 2011, 10:00 am
Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn., and Indianapolis-based Eli Lilly Co. [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
9 Mar 2015, 2:38 pm
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
9 Dec 2010, 3:53 am
" Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
14 Jul 2010, 6:47 pm
Sun Pharmaceutical Industries, Inc. [read post]
3 Mar 2012, 6:48 am
(But not the two new huge drug cases: Boehringer Ingelheim, maker of Pradaxa, is in Connecticut, while Takeda, maker of Actos, is in Illinois.) [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]